8Jul2020
BIA Separations signs two new distribution agreements extending coverage in Asia Pacific
16Jun2020
BIA Separations introduces PrimaS multi-mode ligand bioprocessing technology to facilitate development of advanced therapeutics
19Feb2020
BIA Separations and University of Zagreb Sign License Agreement to Commercialize Novel Elution Method for Virus and Viral Vector purification
13Feb2020
Upon the visit of US Ambassador, BIA Separations announces production expansion to North America
24Jan2020
Purification of drugs is key to their safety and success
10Oct2019
BIA Separations introduces CORNERSTONE Exosome Process Development Solution to Enable Industrial Scale Manufacture of Therapeutic Exosomes
11Sep2019
BIA Separations Introduces Cornerstone AAV Process Development Service to Accelerate Gene Therapy Production
2Sep2019
BIA Separations announced as a finalist in category European CRO of the year
2Sep2019
Platform Purification of Clinical-Quality Bacteriophages published in BioProcess Internationl's Industry Yearbook
22Jul2019
BIA Separations selected for manufacturing process development support for gene therapy pipeline
13May2019
Taming the Last Frontier: Harmonizing the Upstream-Downstream Interface
6Mar2019
BIA Separations recognized as one of the 10 best biotech & pharma companies to keep an eye on in 2019